Expression profiling of BRCA1 and BRCA2 deficient human tumours and cell-lines using a breast specific platform to identify a biomarker of DNA repair deficiency

被引:0
|
作者
Kerr, P.
Mulligan, J.
Farztdinov, V.
McDyer, F.
Halfpenny, I.
Delaney, T.
Couch, F. [1 ]
Quinn, J. [2 ]
Harkin, P.
Kennedy, R.
机构
[1] Mayo Clin, Jacksonville, FL 32224 USA
[2] Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland
来源
EJC SUPPLEMENTS | 2009年 / 7卷 / 04期
关键词
D O I
10.1016/S1359-6349(09)72176-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [41] Association between single nucleotide polymorphisms of DNA repair genes (BRCA1, BRCA2, and PALB2) and breast cancer incidence in a subset of Iranian population
    Jahangiri, Sepideh
    Abdan, Zahra
    Houshmand, Massoud
    Souroush, Ali
    Aznab, Mozaffar
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2025, 23 (01)
  • [42] Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA
    Swami, Umang
    Zimmerman, Raquel Mae
    Nussenzveig, Roberto H.
    Hernandez, Edgar Javier
    Jo, Yeonjung
    Sayegh, Nicolas
    Wesolowski, Sergiusz
    Kiedrowski, Lesli A.
    Barata, Pedro C.
    Lemmon, Gordon Howard
    Bilen, Mehmet A.
    Heath, Elisabeth I.
    Nandagopal, Lakshminarayan
    Babiker, Hani M.
    Pal, Sumanta K.
    Lilly, Michael
    Maughan, Benjamin L.
    Haaland, Benjamin
    Yandell, Mark
    Sartor, Oliver
    Agarwal, Neeraj
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Folic acid supplementation in vitro induces cell type-specific changes in BRCA1 and BRCA 2 mRNA expression, but does not alter DNA methylation of their promoters or DNA repair
    Price, R. Jordan
    Lillycrop, Karen A.
    Burdge, Graham C.
    NUTRITION RESEARCH, 2015, 35 (06) : 532 - 544
  • [44] Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines
    Favy, DA
    Rio, P
    Maurizis, JC
    Hizel, C
    Bignon, YJ
    Bernard-Gallon, DJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 258 (02) : 284 - 291
  • [45] Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients
    Park, See-Hyoung
    Noh, Sang Jae
    Kim, Kyoung Min
    Bae, Jun Sang
    Kwon, Keun Sang
    Jung, Sung Hoo
    Kim, Jung Ryul
    Lee, Ho
    Chung, Myoung Ja
    Moon, Woo Sung
    Kang, Myoung Jae
    Jang, Kyu Yun
    TRANSLATIONAL ONCOLOGY, 2015, 8 (04): : 239 - 249
  • [46] DHX9 inhibition as a novel therapeutic for ovarian and breast cancer with loss-of-function mutations in the DNA damage repair genes BRCA1 or BRCA2
    Castro, Jennifer
    Daniels, Matthew H.
    Pai, Sunaina
    Laidlaw, Monique
    Wu, Jie
    Brennan, David
    Johnston, Brian T.
    Raman, Anugraha
    Lu, Chuang
    Blakemore, Stephen J.
    Silver, Serena J.
    Boriack-Sjodin, P. Ann
    Duncan, Kenneth W.
    Sager, Jason A.
    Copeland, Robert A.
    CANCER RESEARCH, 2024, 84 (01)
  • [47] Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2
    Wang, HC
    Zeng, ZC
    Bui, TA
    DiBiase, SJ
    Qin, W
    Xia, F
    Powell, SN
    Iliakis, G
    CANCER RESEARCH, 2001, 61 (01) : 270 - 277
  • [48] Comprehensive genomic profiling of matched primary prostate cancer tissue and cell-free DNA (cfDNA) to assess ontogeny of BRCA1/BRCA2 mutations.
    McFarland, Taylor Ryan
    Nussenzveig, Roberto
    Swami, Umang
    Sayegh, Nicolas
    Kessel, Adam
    Sharma, Prayushi
    Li Haoran
    Kohli, Manish
    Maughan, Benjamin Louis
    Pal, Sumanta K.
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [49] Deleterious consequences of BRCA1 or BRCA2 mutations via CRISPR-Cas9 in ancestrally distinct triple-negative breast cancer cell lines
    Spears, Marcus
    Ricks-Santi, Luisel
    McDonald, John Tyson
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)
  • [50] Use of DNA-Damaging Agents and RNA Pooling to Assess Expression Profiles Associated with BRCA1 and BRCA2 Mutation Status in Familial Breast Cancer Patients
    Walker, Logan C.
    Thompson, Bryony A.
    Waddell, Nic
    Grimmond, Sean M.
    Spurdle, Amanda B.
    PLOS GENETICS, 2010, 6 (02):